Skip to main content

Breadcrumb

  1. Home

HER2 Breast Cancer

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about HER2 Breast Cancer

FGFR2 (10q26.13)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about FGFR2 (10q26.13)

FGFR3/IgH t(4;14)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about FGFR3/IgH t(4;14)

EWSR1 (22q12)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about EWSR1 (22q12)

RUNX1T1/RUNX1 (ETO/AML1) t(8;21)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about RUNX1T1/RUNX1 (ETO/AML1) t(8;21)

Eosinophilia FISH Panel

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about Eosinophilia FISH Panel

High-Grade B-Cell Lymphoma with 11q Aberration (formerly 11q Aberration in NHL)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about High-Grade B-Cell Lymphoma with 11q Aberration (formerly 11q Aberration in NHL)

EGFR Amplification

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about EGFR Amplification

DUSP22-IRF4 Rearrangement

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about DUSP22-IRF4 Rearrangement

TNFRSF14 (1p36)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:52
  • Read more about TNFRSF14 (1p36)

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • …
  • Next page Next
  • Last page Last
Subscribe to